½ÃÀ庸°í¼­
»óǰÄÚµå
1589696

¼¼°èÀÇ ½ÉÀüµµ ÀåÄ¡ ½ÃÀå : Á¦Ç° À¯Çü, ¸®µå À¯Çü, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Electrocardiogram Equipment Market by Product (Holter Monitors, Resting ECG Systems, Stress ECG Systems), Lead Type (12-Lead Type, 3-6 Lead Type, Single-Lead Type), End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 184 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

½ÉÀüµµ ÀåÄ¡ ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 56¾ï 9,000¸¸ ´Þ·¯·Î, 2024³â¿¡´Â 60¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 6.41%·Î ¼ºÀåÇØ 2030³â¿¡´Â 88¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÉÀüµµ ÀåÄ¡ ½ÃÀåÀº ´Ù¾çÇÑ ½ÉÀå ÁúȯÀÇ Áø´Ü¿¡ ÇʼöÀûÀÎ ½ÉÀåÀÇ Àü±âÀû Ȱµ¿À» ±â·ÏÇÏ´Â Àåºñ¿Í ½Ã½ºÅÛÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â ÈÞ´ë¿ë ÈÞ´ë¿ë Àåºñ¿¡¼­ º¹ÀâÇÑ º´¿ø ½Ã½ºÅÛ¿¡ À̸£±â±îÁö ´Ù¾çÇÑ Àåºñ°¡ Æ÷ÇԵ˴ϴÙ. ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ¿ø°Ý ¸ð´ÏÅ͸µ ±â¼úÀÇ Áøº¸°¡ ÀÌ·¯ÇÑ ÀåºñÀÇ Çʿ伺À» °­Á¶ÇÏ°í º´¿ø, Ŭ¸®´Ð, ÀçÅÃÄ¡·á µî ´Ù¾çÇÑ Àå¸é¿¡¼­ÀÇ ÀÀ¿ëÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. ÃÖÁ¾ ¿ëµµ ºÐ¾ß´Â ¼øÈ¯±â Àü¹®ÀÇ, ÀÏ¹Ý °³¾÷ÀÇ, ȯÀÚ Àڽſ¡°Ô±îÁö ÆÛÁ® ÀÖ¾î, Æø³ÐÀº ÇコÄɾî ÅëÇÕÀ» ½ÇÁõÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ½ÉÀå °Ç°­¿¡ ´ëÇÑ È¯ÀÚÀÇ ÀÇ½Ä Áõ°¡, µðÁöÅÐ °Ç°­ ±â¼úÀÇ Ã¤ÅÃ, Á¶±â Áø´ÜÀ» ÃËÁøÇÏ´Â Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê µîÀÌ ÀÖ½À´Ï´Ù. COVID-19ÀÇ ´ëÀ¯Çà¿¡ ÀÇÇØ °¡¼ÓÈ­µÈ ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀ¸·ÎÀÇ ÀüȯÀº ƯÈ÷ ½ÉÀå Áúȯ ÀÌȯÀ²ÀÌ ³ôÀº °ú¼Ò Áö¿ª¿¡ Å« ±âȸ¸¦ °¡Á®¿Ô½À´Ï´Ù. ÀÌ·¯ÇÑ ±âȸ¸¦ Ȱ¿ëÇÏ·Á¸é ¿¬°á¼º°ú ÅëÇÕ ±â´ÉÀ» Çâ»ó½ÃŲ Àú·ÅÇÑ ÈÞ´ë¿ë ECG ±â±âÀÇ Çõ½ÅÀÌ ÇÊ¿äÇÕ´Ï´Ù. ±×·¯³ª ½ÃÀå ¼ºÀåÀº ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ ¿öÅ©, °í±Þ ECG ÀåºñÀÇ °íºñ¿ë, º¹ÀâÇÑ µ¥ÀÌÅÍ Ãâ·ÂÀ» ÇØ¼®ÇÏ´Â ¼÷·ÃµÈ ±â¼úÀÚÀÇ ºÎÁ·°ú °°Àº ÇѰ迡 Á÷¸é ÇØ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °úÁ¦·Î´Â ºñ¿ë È¿À²ÀûÀÎ ±â¼ú °³¹ß°ú Æ®·¹ÀÌ´× ÇÁ·Î±×·¥ÀÇ 2°³¼³ÀÌ ÇÊ¿äÇÕ´Ï´Ù. Çõ½Å ±â¼úÀÌ Àͼ÷ÇÑ ºÐ¾ß·Î´Â ¿þ¾î·¯ºí ECG ±â¼ú, ¿¹Ãø ¹× ºÐ¼®À» À§ÇÑ ÀΰøÁö´É, º¸´Ù ±¤¹üÀ§ÇÑ ÀÇ·á »ýÅÂ°è ³» ÀåºñÀÇ »óÈ£ ¿î¿ë¼º °­È­ µîÀÌ ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ Æ¯¼ºÀ» »ìÆìº¸¸é ±â¼úÀÇ Áøº¸°¡ ÁøÇàµÇ´Â °æÀï ±¸µµÀÌ ºÐ¸íÇØÁö¸ç, °øµ¿ ¿¬±¸¿Í ÆÄÆ®³Ê½ÊÀÌ È®À强 ´Þ¼º°ú ¹Ì°³Ã´ ½ÃÀå ÁøÀÔ¿¡ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀ» Ž»öÇÏ·Á¸é ±ÔÁ¦ ȯ°æ¿¡ ´ëÇÑ ¿¹¸®ÇÑ Àνİú R&D ÅõÀÚ¿¡ ´ëÇÑ Àû±ØÀûÀÎ Á¢±ÙÀÌ ÇÊ¿äÇÕ´Ï´Ù. ±â¼úÀûÀÎ Á¤±³ÇÔ°ú Àú·ÅÇÑ °¡°Ý°ú Á¢±Ù¼º °£ÀÇ ±ÕÇüÀº ½ÃÀå¿¡ ´ëÇÑ ½ÇÁúÀûÀΠħÅõ¿Í ºñÁî´Ï½º ¼ºÀå¿¡ ¿©ÀüÈ÷ Áß¿äÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 56¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 60¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 88¾ï ´Þ·¯
CAGR(%) 6.41%

½ÃÀå ¿ªÇÐ: ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ½ÉÀüµµ ÀåÄ¡ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

½ÉÀüµµ ÀåÄ¡ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ±×¸®°í »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñ ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¶óÀÌÇÁ ½ºÅ¸ÀÏÀÇ ±Þ°ÝÇÑ º¯È­¿¡ ÀÇÇÑ ¼¼°èÀÇ ½ÉÇ÷°ü Áúȯ Áõ°¡
    • ¼¼°èÀÇ °í·ÉÈ­ Àα¸ÀÇ ±ÞÁõ°ú ½ÉÇ÷°ü ÁúȯÀÇ Á¶±â Áø´ÜÀÇ Çʿ伺
    • ¿þ¾î·¯ºí ¹× ¹«¼± ¿ø°Ý ¸ð´ÏÅ͸µ ±â±âÀÇ Ã¤¿ë
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ºÒ¸®ÇÑ »óȯ Á¤Ã¥ÀÇ ¹®Á¦
  • ½ÃÀå ±âȸ
    • ÇコÄɾî ÀÎÇÁ¶ó¿¡ ´ëÇÑ Á¤ºÎÀÇ Áö¿øÃ¥
    • ½ÉÀüµµ ÀåÄ¡ÀÇ Áøº¸
  • ½ÃÀåÀÇ °úÁ¦
    • ÷´Ü ±â±â¸¦ Á¶ÀÛÇÏ´Â ¼÷·ÃµÈ Àü¹® Áö½ÄÀÇ ºÎÁ·

Porter's Five Forces: ½ÉÀüµµ Àåºñ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ½ÉÀüµµ Àåºñ ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂûÀ» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ½ÉÀüµµ ÀåÄ¡ ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ½ÉÀüµµ Àåºñ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇϴµ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ½ÉÀüµµ Àåºñ ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

½ÉÀüµµ Àåºñ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í °ø±Þ¾÷ü´Â °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ½ÉÀüµµ Àåºñ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ½ÉÀüµµ Àåºñ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ½ÉÀüµµ Àåºñ ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

½ÉÀüµµ ÀåÄ¡ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ Á¸À縦 °­È­ÇÏ·Á´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ±Þ¼ÓÇÏ°Ô º¯È­ÇÏ´Â ¶óÀÌÇÁ ½ºÅ¸ÀÏ¿¡ ÀÇÇØ ¼¼°è¿¡¼­ ½ÉÇ÷°ü ÁúȯÀÇ ¹ß»ý·üÀÌ »ó½ÂÇϰí ÀÖ´Ù
      • ¼¼°èÀÇ °í·ÉÈ­ Àα¸ÀÇ ±ÞÁõ°ú ½ÉÇ÷°ü ÁúȯÀÇ Á¶±â Áø´ÜÀÇ Çʿ伺
      • ¿þ¾î·¯ºí ¹× ¹«¼± ¿ø°Ý °¨½Ã ÀåÄ¡ÀÇ µµÀÔ
    • ¾ïÁ¦¿äÀÎ
      • ºÒ¸®ÇÑ È¯ºÒ Á¤Ã¥ °ü·Ã ¹®Á¦
    • ±âȸ
      • ÇコÄɾî ÀÎÇÁ¶ó¿¡ ´ëÇÑ Á¤ºÎÀÇ Áö¿øÃ¥
      • ½ÉÀüµµ ÀåÄ¡ÀÇ Áøº¸
    • °úÁ¦
      • °í±Þ ±â±â¸¦ Á¶ÀÛÇϱâ À§ÇÑ ¼÷·ÃµÈ Àü¹® Áö½ÄÀÇ ºÎÁ·
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ½ÉÀüµµ ÀåÄ¡ ½ÃÀå : Á¦Ç°º°

  • ȦÅÍ ¸ð´ÏÅÍ
  • È޽Ľà ½ÉÀüµµ ½Ã½ºÅÛ
  • ½ºÆ®·¹½º ½ÉÀüµµ ½Ã½ºÅÛ

Á¦7Àå ½ÉÀüµµ ÀåÄ¡ ½ÃÀå : ¸®µå À¯Çüº°

  • 12 ¸®µå À¯Çü
  • 3-6 ¸®µå À¯Çü
  • ½Ì±Û ¸®µå À¯Çü

Á¦8Àå ½ÉÀüµµ ÀåÄ¡ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ÀçÅà ÄÉ¾î ¶Ç´Â ¿Ü·¡ Äɾî
  • º´¿ø

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ½ÉÀüµµ ÀåÄ¡ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÉÀüµµ ÀåÄ¡ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ½ÉÀüµµ ÀåÄ¡ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Baxter International Inc.
  • CardioComm Solutions, Inc.
  • CompuMed, Inc.
  • Device Technologies Australia Pty Ltd.
  • Dragerwerk AG & Co. KGaA
  • General Electric Company
  • Koninklijke Philips NV
  • McKesson Corporation
  • Medical ECONET GmbH
  • Meditech Equipment Co., Ltd.
  • Mindray Bio-Medical Electronics Co., Ltd.
  • Nihon Kohden Corporation
  • OSI Systems, Inc.
  • Schiller AG
  • ZOLL Medical Corporation
JHS 24.11.21

The Electrocardiogram Equipment Market was valued at USD 5.69 billion in 2023, expected to reach USD 6.05 billion in 2024, and is projected to grow at a CAGR of 6.41%, to USD 8.80 billion by 2030.

The Electrocardiogram Equipment market encompasses the devices and systems used for recording the electrical activity of the heart, crucial for diagnosing various cardiac conditions. This market spans a range of equipment from portable handheld devices to complex hospital systems. The growing prevalence of cardiovascular diseases, coupled with advancements in remote monitoring technology, underscores the necessity of these devices, enhancing their application in diverse settings like hospitals, clinics, and even home care. End-use segments extend to cardiologists, general practitioners, and patients themselves, demonstrating broad healthcare integration. Key factors driving market growth include increasing patient awareness about cardiac health, the adoption of digital health technologies, and government initiatives fostering early diagnosis. The shift toward telemedicine and remote patient monitoring, accelerated by the COVID-19 pandemic, presents significant opportunities, especially in underpenetrated regions with high cardiac disease incidence. Capitalizing on these opportunities would involve innovating affordable, portable ECG devices with improved connectivity and integration capabilities. However, market growth faces limitations such as strict regulatory frameworks, the high cost of advanced ECG devices, and the scarcity of skilled technicians to interpret complex data outputs. These challenges necessitate a dual focus on cost-effective technology development and training programs. Areas ripe for innovation include wearable ECG technology, artificial intelligence for prediction and analysis, and enhancing device interoperability within broader health ecosystems. Insight into market nature reveals a competitive landscape with ongoing technological advancements, where collaborations and partnerships can play a pivotal role in achieving scalability and reaching underserved markets. Navigating this market requires an acute awareness of regulatory environments and a proactive approach to R&D investment. Balancing technological sophistication with affordability and accessibility remains critical for substantial market penetration and business growth.

KEY MARKET STATISTICS
Base Year [2023] USD 5.69 billion
Estimated Year [2024] USD 6.05 billion
Forecast Year [2030] USD 8.80 billion
CAGR (%) 6.41%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Electrocardiogram Equipment Market

The Electrocardiogram Equipment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rapidly changing lifestyles increase the incidence of cardiovascular diseases worldwide
    • Surge in global aging population and need for early diagnosis of cardiovascular conditions
    • Adoption of wearable and wireless remote monitoring devices
  • Market Restraints
    • Issues with unfavorable reimbursement policies
  • Market Opportunities
    • Supportive government initiatives for healthcare infrastructure
    • Advancements in electrocardiogram equipment
  • Market Challenges
    • Lack of skilled expertise to operate advanced equipment

Porter's Five Forces: A Strategic Tool for Navigating the Electrocardiogram Equipment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Electrocardiogram Equipment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Electrocardiogram Equipment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Electrocardiogram Equipment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Electrocardiogram Equipment Market

A detailed market share analysis in the Electrocardiogram Equipment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Electrocardiogram Equipment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Electrocardiogram Equipment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Electrocardiogram Equipment Market

A strategic analysis of the Electrocardiogram Equipment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Electrocardiogram Equipment Market, highlighting leading vendors and their innovative profiles. These include Baxter International Inc., CardioComm Solutions, Inc., CompuMed, Inc., Device Technologies Australia Pty Ltd., Dragerwerk AG & Co. KGaA, General Electric Company, Koninklijke Philips N.V., McKesson Corporation, Medical ECONET GmbH, Meditech Equipment Co., Ltd., Mindray Bio-Medical Electronics Co., Ltd., Nihon Kohden Corporation, OSI Systems, Inc., Schiller AG, and ZOLL Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Electrocardiogram Equipment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Holter Monitors, Resting ECG Systems, and Stress ECG Systems.
  • Based on Lead Type, market is studied across 12-Lead Type, 3-6 Lead Type, and Single-Lead Type.
  • Based on End-User, market is studied across Home or Ambulatory Care and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rapidly changing lifestyles increase the incidence of cardiovascular diseases worldwide
      • 5.1.1.2. Surge in global aging population and need for early diagnosis of cardiovascular conditions
      • 5.1.1.3. Adoption of wearable and wireless remote monitoring devices
    • 5.1.2. Restraints
      • 5.1.2.1. Issues with unfavorable reimbursement policies
    • 5.1.3. Opportunities
      • 5.1.3.1. Supportive government initiatives for healthcare infrastructure
      • 5.1.3.2. Advancements in electrocardiogram equipment
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled expertise to operate advanced equipment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Electrocardiogram Equipment Market, by Product

  • 6.1. Introduction
  • 6.2. Holter Monitors
  • 6.3. Resting ECG Systems
  • 6.4. Stress ECG Systems

7. Electrocardiogram Equipment Market, by Lead Type

  • 7.1. Introduction
  • 7.2. 12-Lead Type
  • 7.3. 3-6 Lead Type
  • 7.4. Single-Lead Type

8. Electrocardiogram Equipment Market, by End-User

  • 8.1. Introduction
  • 8.2. Home or Ambulatory Care
  • 8.3. Hospitals

9. Americas Electrocardiogram Equipment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Electrocardiogram Equipment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Electrocardiogram Equipment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Baxter International Inc.
  • 2. CardioComm Solutions, Inc.
  • 3. CompuMed, Inc.
  • 4. Device Technologies Australia Pty Ltd.
  • 5. Dragerwerk AG & Co. KGaA
  • 6. General Electric Company
  • 7. Koninklijke Philips N.V.
  • 8. McKesson Corporation
  • 9. Medical ECONET GmbH
  • 10. Meditech Equipment Co., Ltd.
  • 11. Mindray Bio-Medical Electronics Co., Ltd.
  • 12. Nihon Kohden Corporation
  • 13. OSI Systems, Inc.
  • 14. Schiller AG
  • 15. ZOLL Medical Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦